The treatment of pulmonary embolism includes thrombolytic therapy and anticoagulant therapy, and different treatment methods are adopted according to the types of pulmonary embolism.
Thrombolytic therapy is the first choice for acute pulmonary embolism, and streptokinase and urokinase are commonly used thrombolytic drugs. It is necessary to monitor the changes of coagulation and platelets during thrombolysis.
Anticoagulation therapy can be considered after thrombolysis or when there is no indication of thrombolysis. Commonly used anticoagulants include heparin, low molecular weight heparin, warfarin, rivaroxaban and dabigatran. In the process of anticoagulation, we should pay attention to monitoring the change of international standardized value to keep it between two and three times.
If the above treatment fails, intervention or surgery can be considered, and thrombolysis and anticoagulation are the main clinical methods.
The above scheme is for reference only. Please follow the drug instructions or doctor's advice to use drugs in regular hospitals.